Figure 4
From: Morphometric imaging biomarker identifies Alzheimer’s disease even among mixed dementia patients
The sensitivity and specificity of the skin fibroblast-based Morphometric Imaging assay and the 95% confidence intervals.
Figure 4 | Scientific Reports
